Tanning beds triple melanoma risk, potentially causing broad DNA damage
December 12, 2025
Study is first to show how tanning beds mutate skin cells far beyond the reach of ordinary sunlight
Study is first to show how tanning beds mutate skin cells far beyond the reach of ordinary sunlight
The Spring is the only FDA-approved FIT in a range of lengths and diameters, allowing for patient personalisation
A study published in the Journal of Clinical Oncology confirms that one of the first Food and Drug Administration-approved CAR-T cell therapies offers long-term survival and potential cures for adult patients with relapsed or refractory large B-cell lymphoma, even years after treatment.
Heart muscle cells grown from patient stem cells—known as human induced pluripotent stem cell–derived cardiomyocytes, or hiPSC-CMs—are a promising way to repair hearts damaged by heart attacks and heart failure.
Flow Neuroscience’s at-home depression treatment device has become the first of its kind to be approved by the FDA.
Lumos Labs’ LumosityRx is positioned for use alongside other ADHD treatment modalities such as medication and therapy.
Synaptic plasticity—the brain’s ability to modify the connections between neurons to support learning—is one of the neural functions profoundly altered in Huntington’s disease, with a direct impact on brain function.
In Brazil, researchers from the Federal University of Grande Dourados (UFGD), the State University of Campinas (UNICAMP), and São Paulo State University (UNESP) have conducted a study that confirmed the safety and anti-inflammatory, analgesic, and anti-arthritic properties of the Joseph’s Coat plant (Alternanthera littoralis).
Ceribell (Nasdaq:CBLL) announced that it received FDA 510(k) clearance for its proprietary delirium monitoring solution.
HeartBeam (Nasdaq:BEAT) announced today that it received FDA 510(k) clearance for its 12-lead electrocardiogram (ECG) synthesis software.